Big Pharma’s Big Fines

Posted on Mar 16, 2014 in Uncategorized

In the last few years pharmaceutical companies have agreed to pay over $13 billion to resolve U.S. Department of Justice allegations of fraudulent marketing practices, including the promotion of medicines for uses that were not approved by the Food and Drug Administration. Here are summaries of some recent large settlements.

Click Here to see the settlements